Nordic Nanovector: Presentations at European Association of Nuclear Medicine annual meeting (EANM)
(WorldNews Norway)

Oslo, Norway, 23 October 2017 Nordic Nanovector ASA (OSE: NANO) announces the following presentations by the company`s research collaborators at the European Association of Nuclear Medicine annual meeting (EANM; 21-25 October; Vienna, Austria). Abstract: OP-012 Title: Pre-dosing with lilotomab prior to antibody-radionuclide conjugate therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumour to red marrow absorbed dose in non-Hodgkin lymphoma patients Authors: J. Blakkisrud et al. Abstract: OP-054 Title: Involvement of cell cycle checkpoints in the therapeutic efficacy of 177Lu-lilotomab in non-Hodgkin B-cell lymphoma Authors: A. Pichard et al. Abstract: EP-0814...